Full Length Research Paper
References
|
Brion F, Nunn AJ, Rieutord A (2003). Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatric 92:486-490. |
|
|
Buurma H, de Sme TP, van den Hoff OP, Sysling H, Storimans M, Egberts ACG (2003). Frequency, nature and determinates of pharmacy compounded medicines in Dutch community pharmacies. Pharm. World Sci. 25(6):280-287. |
|
|
Donnelly R, McNally M, Barry J (2008). Is extemporaneous dispensing really in the best interest of patients? Pharm. J. 280:251-254. |
|
|
Eisler P, Schnaars C (2014). Safety, sanitary problems prompt scores of drug recalls. |
|
|
Eley JG, Birnie C (2006). Retention of compounding skills among pharmacy students. Am. J. Pharm. Edu. 70(6):132. |
|
|
Feldschuh M (2008). Compounding in community pharmacy. Austr. Prescriber 31(2):30-31. |
|
|
Food and Drug Administration (2006). 2006 Limited FDA Survey of Compounded Drug Products. h |
|
|
Flores-Perez C, Flores-Perez J, Juarez-Olguin H, Barranco-Garduano D (2008). Frequency of drug consumption and lack of pediatric formulations. Acta Pediatric de Mexico 29(1):16-19. |
|
|
Giam J, McLachlan AJ (2008). Extemporaneous product use in paediatricpatients: A systemic review. Int. Pharm. Pract. 16:3-10. |
|
|
Giam JA, McLachlan AJ, Krass I (2012). Characterizing specialized compounding in community pharmacies. Res. Soc. Adm. Pharm. 8(3):240-252. |
|
|
Gross Z (2005). Why special manufacturing units are needed now as much as they were ever. Pharm. J. 275:743-744. |
|
|
Haywood B, Glass A (2007). Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products. J. Pharm. Pract. Res. 37:131-133. |
|
|
Kairuz T, Chhim S, Hasan F, Kumar K, Lal A, Patel R,Singh R, Dogra M, Garg S (2007a). Extemporaneous compounding in a sample of New Zealand hospitals: A retrospective survey. New Zealand Med. J. 120:1251. |
|
|
Kairuz TE, Gargiulo D, Bunt C, Garg S (2007b). Quality, Safety and Efficacy in the 'Off-Label' Use of Medicines. Curr. Drug Safe. 2:89-95. |
|
|
Limpopo Department of Health and Social Development (2008). Final Limpopo DHSD 2008/09 -11 Annual Performance Plan - Vote 7. Republic of South Africa: Limpopo Provincial Government. |
|
|
Morris AM, Schneider PJ, Pederson CA, Mirtallo JM (2003). National survey of quality assurance activities for pharmacy-compounded sterile preparations. Am. J. Health-System Pharm. 60(24):2567-2576. |
|
|
Nahata MC, Allen LV (2008). Extemporaneous Drug Formulations. Clin. Ther. 30(11):2112-2119. |
|
|
Nunn AJ (2003). Making medicines that children can take. Arch. Dis. Childhood 88:369-371. |
|
|
Salgado AC, Rosa ML, Duarte MA, Almeida AJ (2005). Stability of spironolactone in an extemporaneously prepared aqueous suspension: The importance of microbiological quality of compounded paediatric formulations. Eur. J. Hosp. Pharm. Sci. 11(3):68-73 |
|
|
Schultz M (2007). Compounding products in a non-manufacturing environment. Health Sci. Acad. Professional Pract. 7(2):4-6. |
|
|
Shah M, Sandler L, Rai V, Sharma C, Raghavan L (2013). Quality of compounded topical 2% diltiazem hydrochloride formulations for anal fissure. World J. Gastroenterol.  19(34):5645–5650. |
|
|
Shaughnessy AF (2012). Meningitis outbreak shines light on compounding pharmacies. Br. Med. J. 345:e7432 |
|
|
Snyman T, Stewart MJ, Grove A, Steenkamp V (2005). Adulteration of South African Traditional Herbal Remedies. Ther. Drug Monitor. 27(1):86-89. |
|
|
Spark MJ (2014). Compounding of medicines by pharmacies: An update. Maturitas 78:239-240. |
|
|
Standing J, Tuleu C (2005). Paediatric formulations – Getting to the heart of the problem. J. Pharm. 300:55-56. |
|
|
Statistics South Africa (2007). Community Survey, 2007 Basic Results: Municipalities. Statistical release P0301.1. |
|
|
Steward D, Rou FA, Snaith A, Elliot K, Peter J, McLay HJ (2007). Attitude and experiences of community pharmacists towards pediatric off-label prescribing: A prospective survey. Br. J. Clin. Pharm. 64(1):90-95. |
|
|
Treadway A, Craddock D, Leef R (2007). Practices of Pharmacies that compound extemporaneous formulations. Am. J. Health Syst. Pharm. 64:1403-1409. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
